News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Fenebrutinib reduces disability progression in primary progressive MS

February 10, 2026

Phase III results show investigational fenebrutinib met primary endpoint of no-inferiority compared to Ocrevus in reducing disability progression in PPMS.
Learn more

Researchers are closer to finding Epstein-Barr virus, MS link

February 09, 2026

“Killer” T immune cells may play key role in disease.
Learn more

Study finds backward walking may improve gait in MS patients

February 06, 2026

Findings offer potential new treatment to promote neuroplasticity.
Learn more

Study suggests mindset is central to walking experience

January 26, 2026

Findings uncover the effects of stigma and emotion of walking with MS.
Learn more

Study sheds new light on link between Epstein-Barr and MS

January 14, 2026

The new findings suggest that, rather than acting only indirectly, B cells may also play a direct role at the earliest stages of lesion formation.
Learn more

Findings suggest oral bacterium, MS disability severity link

January 07, 2026

Researchers think there is a need to evaluate whether dental interventions may modify disease activity or disability progression in MS.
Learn more

Exposure to PFAS and PCBs may be linked to higher odds of MS

December 22, 2025

Study highlights how environmental contaminants can interact with hereditary factors.
Learn more

Study suggests certain gut bacteria may drive MS

December 16, 2025

“Molecular mimicry” may contribute to disease progression.
Learn more

Missing piece of myelin found to disturb the brain’s rhythm

December 15, 2025

Researchers liken myelin damage to the disruption to a supermarket barcode.
Learn more

Fenebrutinib reduces disability progression in primary progressive MS

February 10, 2026

Phase III results show investigational fenebrutinib met primary endpoint of no-inferiority compared to Ocrevus in reducing disability progression in PPMS.
Learn more

Researchers are closer to finding Epstein-Barr virus, MS link

February 09, 2026

“Killer” T immune cells may play key role in disease.
Learn more

Study finds backward walking may improve gait in MS patients

February 06, 2026

Findings offer potential new treatment to promote neuroplasticity.
Learn more

Study suggests mindset is central to walking experience

January 26, 2026

Findings uncover the effects of stigma and emotion of walking with MS.
Learn more

Study sheds new light on link between Epstein-Barr and MS

January 14, 2026

The new findings suggest that, rather than acting only indirectly, B cells may also play a direct role at the earliest stages of lesion formation.
Learn more

Findings suggest oral bacterium, MS disability severity link

January 07, 2026

Researchers think there is a need to evaluate whether dental interventions may modify disease activity or disability progression in MS.
Learn more

Exposure to PFAS and PCBs may be linked to higher odds of MS

December 22, 2025

Study highlights how environmental contaminants can interact with hereditary factors.
Learn more

Study suggests certain gut bacteria may drive MS

December 16, 2025

“Molecular mimicry” may contribute to disease progression.
Learn more

Missing piece of myelin found to disturb the brain’s rhythm

December 15, 2025

Researchers liken myelin damage to the disruption to a supermarket barcode.
Learn more

Sandoz launches Tyruko in U.S. as first and only MS biosimilar

November 20, 2025

Tyruko approved for all indications of reference medicine Tysabri.
Learn more

Study suggests BTK inhibitor slows MS disability progression as effectively as Ocrevus

November 12, 2025

Genentech’s fenebrutinib shows positive phase III results as the potential first BTK inhibitor in both relapsing and primary progressive MS.
Learn more

Study maps brain development and how it resolves inflammation

November 06, 2025

Findings could offer insights into how MS develops and provide new tools for treating the disease.
Learn more

Study reveals the hidden burden of MS on quality of life

October 30, 2025

Findings highlight the need for healthcare services to recognize the effect of MS on wellbeing across all age groups.
Learn more

Study suggests MS harms a brain long before symptoms appear

October 23, 2025

Signaling protein may hold key to early diagnosis.
Learn more

Scientists claim X-chromosome gene linked to MS

October 22, 2025

Mouse study reveals how females' double X chromosomes drive brain inflammation and identifies diabetes drug as potential treatment.
Learn more

Study finds estrogen could aid in progressive MS therapies

October 21, 2025

Researchers studied the protective effects of estradiol and estriol on the myelin sheath.
Learn more

Inflammatory brain cells driving progressive MS are discovered

October 14, 2025

Findings provide promising new avenue for research into more effective therapies.
Learn more

Scientists identify two compounds that may help people with MS

October 10, 2025

Lead candidate promotes remyelination and modulates immune function, researchers claim.
Learn more


Show More News